TACTILE SYSTEMS TECHNOLOGY I
TCMDNASDAQTrading Snapshot
- Day Range
- $22.34 – $22.62
- 52-Week Range
- $13.39 – $37.77
- Volume
- $2.00B
- Avg Volume
- $1.35B
- Shares Outstanding
- 22.6M
- Next Earnings
- Oct 29, 2026
Fundamentals Snapshot
- Annual Revenue
- $330M
- Last Q Revenue
- $86M
- P/E Ratio
- 20.9
- P/S Ratio
- 1.5x
- EPS (TTM)
- $1.08
- Dividend Yield
- —
- Dilution (1yr)
- −5.8%
Why Investors Own TCMD
- ✓High-growth profile — revenue up +53.7% YoY with expanding US Equity exposure.
- ✓Healthy economics — 79% gross margin and 26% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
TACTILE SYSTEMS TECHNOLOGY I
TCMD
StockOtter · stockotter.spaceAbout TACTILE SYSTEMS TECHNOLOGY I
Tactile Systems Technology, Inc. is a medical technology firm that develops and supplies specialized devices to treat chronic health conditions across the United States. Its product portfolio features the Flexitouch Plus system, a pneumatic compression device designed for managing lymphedema. The company also offers the Entre system, a portable pneumatic compression solution for at-home treatment of various venous disorders, including lymphedema, chronic venous insufficiency, and venous leg ulcers. Additionally, Tactile Systems provides the AffloVest, a portable high-frequency chest wall oscillation device used to address retained pulmonary secretions associated with conditions such as bronchiectasis, cystic fibrosis, and certain neuromuscular disorders. Established in 1995, the company maintains its headquarters in Minneapolis, Minnesota.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Price Target
ⓘLatest News & Updates
Tactile Systems Technology, Inc. (TCMD) Q2 2026 Earnings Call Transcript
Tactile Systems Technology, Inc. (TCMD) Q2 2026 Earnings Call Transcript
Tactile Systems Technology Q2 Earnings Call Highlights
Tactile Systems Technology NASDAQ: TCMD, doing business as Tactile Medical, reported second-quarter revenue growth and higher profitability, led by its lymphedema business, while updating its full-year outlook to reflect
Tactile Systems Technology (TCMD) Beats Q2 Earnings and Revenue Estimates
Tactile Systems Technology (TCMD) came out with quarterly earnings of $0.34 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.14 per share a year ago.
Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026
MINNEAPOLIS, July 21, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today
Tactile Medical Enters Exclusive U.S. Distribution Agreement with ElastiMed for its MyoSleeve™ Wearable Compression Device for VA and DoD Patients
Discreet, Battery-Powered Device Reaches Patients at Earlier Stages of Disease Progression Discreet, Battery-Powered Device Reaches Patients at Earlier Stages of Disease Progression
Tactile Systems Technology (TCMD) Moves 8.1% Higher: Will This Strength Last?
Tactile Systems Technology (TCMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.